Spots Global Cancer Trial Database for squamous cell lung cancer
Every month we try and update this database with for squamous cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Icotinib for Completed Resected IB NSCLC With EGFR Mutation | NCT02264210 | Lung Neoplasms Squamous Cell L... Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Bronchial Neopl... Stage IB Non-sm... | Icotinib | 18 Years - 75 Years | Sun Yat-sen University | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00661193 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery | NCT00551369 | Lung Cancer | SBRT | 18 Years - | Radiation Therapy Oncology Group | |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction | NCT00009789 | Lung Cancer | accelerated con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer | NCT01824901 | Recurrent Non-s... Squamous Cell L... | docetaxel AZD4547 | 25 Years - | Eastern Cooperative Oncology Group | |
| S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00085501 | Lung Cancer | cetuximab carboplatin paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC | NCT02852083 | Squamous Cell L... Non-Squamous Ce... Non-Small Cell ... | Pioglitazone nivolumab Treosulfan Clarithromycin | 18 Years - | University Hospital Regensburg | |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC | NCT02059967 | Adenocarcinoma ... Large Cell Lung... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | Paclitaxel image-guided ad... carboplatin | 18 Years - | Virginia Commonwealth University | |
| TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers | NCT04485013 | Cancer | TTX-080 TTX-080 pembrolizumab cetuximab | 18 Years - | Tizona Therapeutics, Inc | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer | NCT03866993 | Lung Cancer Non... Squamous Cell L... | AK105 Paclitaxel Carboplatin Placebo | 18 Years - 75 Years | Akeso | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | NCT00006458 | Lung Cancer | indium In 111 m... yttrium Y 90 mo... | 18 Years - | National Cancer Institute (NCI) | |
| Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer | NCT00365183 | Non-Small Cell ... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer | NCT00365183 | Non-Small Cell ... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | NCT00087438 | Lung Cancer | stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | NCT00066651 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer | NCT01784640 | Recurrent Non-s... Squamous Cell L... Stage IV Non-sm... | Hsp90 inhibitor... pemetrexed diso... pharmacological... laboratory biom... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC | NCT02059967 | Adenocarcinoma ... Large Cell Lung... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | Paclitaxel image-guided ad... carboplatin | 18 Years - | Virginia Commonwealth University | |
| Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00023673 | Lung Cancer | carboplatin paclitaxel three-dimension... | - | Radiation Therapy Oncology Group | |
| Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003202 | Lung Cancer | cisplatin gemcitabine hyd... radiation thera... | - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00005838 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | shark cartilage... placebo cisplatin vinorelbine tar... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | NCT00033410 | Lung Cancer | carboplatin paclitaxel tirapazamine radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT01345851 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... laboratory biom... image-guided ra... carboplatin paclitaxel stereotactic bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00117962 | Lung Cancer | cetuximab carboplatin pemetrexed diso... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Exhaled Breath Particles in Lung Cancer | NCT05395611 | Lung Cancer Non-small Cell ... Lung Adenocarci... Squamous Cell L... | EBPcollected us... | 16 Years - 90 Years | Lund University Hospital | |
| Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001 | NCT03574818 | Squamous Cell L... | Necitumumab-Gem... Evaluation to d... | 18 Years - | Montefiore Medical Center | |
| Prevalence of EGFR Mutations in epidermoïd Bronchopulmonary Cancers in Réunion Island | NCT04261725 | Squamous Cell L... | EGFR mutation | 18 Years - | Centre Hospitalier Universitaire de la Réunion | |
| A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | NCT02583542 | Triple-Negative... Squamous Cell L... Non-squamous Ce... Non-squamous Ce... | AZD2014 AZD6244 | 18 Years - | Queen Mary University of London | |
| Photodynamic Therapy for the Prevention of Lung Cancer | NCT03346304 | Squamous Cell L... Lung Cancer | Photodynamic Th... | 18 Years - | University College, London | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00026156 | Lung Cancer | docetaxel vinorelbine tar... | 18 Years - | SWOG Cancer Research Network | |
| Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | NCT05292859 | Gynecologic Can... Colorectal Canc... Pancreatic Canc... Non-small Cell ... Cholangiocarcin... Ovarian Cancer Ovary Neoplasm Squamous Cell L... Adenocarcinoma ... Adenosquamous C... | Neoantigen spec... | 18 Years - | Alaunos Therapeutics | |
| Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy | NCT00093132 | Carcinoma, Non-... Lung Cancer | Satraplatin | 18 Years - | Agennix | |
| SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002642 | Lung Cancer | cisplatin etoposide conventional su... low-LET cobalt-... | 18 Years - | SWOG Cancer Research Network | |
| Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens | NCT01948141 | Recurrent Non-s... Squamous Cell L... Stage III Non-s... Stage IV Non-sm... | nintedanib | 18 Years - | Roswell Park Cancer Institute | |
| Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer | NCT00955695 | Lung Cancer | erlotinib hydro... gefitinib questionnaire a... quality-of-life... whole-brain rad... | 18 Years - | National Cancer Institute (NCI) | |
| Prevalence of EGFR Mutations in epidermoïd Bronchopulmonary Cancers in Réunion Island | NCT04261725 | Squamous Cell L... | EGFR mutation | 18 Years - | Centre Hospitalier Universitaire de la Réunion | |
| A Study of ZEN003694 in People With Squamous Cell Lung Cancer | NCT05607108 | Squamous Cell L... | ZEN003694 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer | NCT00090961 | Lung Cancer Pulmonary Compl... | educational int... supervised exer... | - | SWOG Cancer Research Network | |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status | NCT00986297 | Lung Cancer | hypofractionate... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer | NCT01139944 | Lung Cancer | DNA methylation... polymerase chai... laboratory biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00217698 | Lung Cancer | cisplatin gefitinib gemcitabine hyd... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch | NCT05550961 | NSCLC Cancer Lung Cancer Adenocarcinoma ... Squamous Cell L... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | ||
| Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers | NCT02423590 | Squamous Cell L... | Apatorsen (OGX-... Gemcitabine Carboplatin | 18 Years - | Queen Mary University of London | |
| Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00023673 | Lung Cancer | carboplatin paclitaxel three-dimension... | - | Radiation Therapy Oncology Group | |
| Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00217698 | Lung Cancer | cisplatin gefitinib gemcitabine hyd... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | NCT00002852 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IB Non-sm... | paclitaxel carboplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | NCT00087438 | Lung Cancer | stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | NCT00081302 | Lung Cancer | cetuximab carboplatin paclitaxel radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer | NCT00025571 | Lung Cancer | HPPH | 18 Years - | Roswell Park Cancer Institute | |
| Autologous Natural Killer T Cells Infusion for the Treatment of Cancer | NCT01801852 | Breast Cancer Glioma Hepatocellular ... Squamous Cell L... Pancreatic Canc... Colon Cancer Prostate Cancer | NKT cells | 18 Years - 90 Years | Chinese PLA General Hospital | |
| Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00268489 | Lung Cancer | bevacizumab pemetrexed diso... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer | NCT02787473 | Squamous Cell L... | pemetrexed cisplatin thoracic radiat... docetaxel | 18 Years - 75 Years | First People's Hospital of Hangzhou | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | NCT00006458 | Lung Cancer | indium In 111 m... yttrium Y 90 mo... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00346320 | Lung Cancer | 3-dimensional c... | 18 Years - | Canadian Cancer Trials Group | |
| Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | NCT00042835 | Adenocarcinoma ... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | cisplatin etoposide erlotinib hydro... radiation thera... docetaxel paclitaxel carboplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Photodynamic Therapy for the Prevention of Lung Cancer | NCT03346304 | Squamous Cell L... Lung Cancer | Photodynamic Th... | 18 Years - | University College, London | |
| Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | NCT00003387 | Lung Cancer | carboplatin chemotherapy paclitaxel radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed | NCT00003235 | Lung Cancer | carboplatin paclitaxel radiation thera... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers | NCT02423590 | Squamous Cell L... | Apatorsen (OGX-... Gemcitabine Carboplatin | 18 Years - | Queen Mary University of London | |
| A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) | NCT00102505 | Non-Small-Cell ... Carcinoma, Bron... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00005850 | Anxiety Disorde... Depression Fatigue Lung Cancer | cisplatin fluoxetine gemcitabine hyd... | - | Alliance for Clinical Trials in Oncology | |
| Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | NCT00003387 | Lung Cancer | carboplatin chemotherapy paclitaxel radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | NCT02583542 | Triple-Negative... Squamous Cell L... Non-squamous Ce... Non-squamous Ce... | AZD2014 AZD6244 | 18 Years - | Queen Mary University of London | |
| S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00085501 | Lung Cancer | cetuximab carboplatin paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | NCT00028938 | Lung Cancer | epoetin alfa carboplatin paclitaxel radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00006378 | Lung Cancer | carboplatin paclitaxel radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer | NCT00526461 | Lung Cancer | HPPH | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00077311 | Anemia Drug/Agent Toxi... Lung Cancer Neutropenia | darbepoetin alf... pegfilgrastim cisplatin docetaxel BNP7787 | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00326599 | Lung Cancer | carboplatin cediranib malea... gemcitabine hyd... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00004139 | Lung Cancer | docetaxel gemcitabine hyd... irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients | NCT00030771 | Lung Cancer | Chemotherapy Radiotherapy Surgery | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| Photodynamic Therapy for the Prevention of Lung Cancer | NCT03346304 | Squamous Cell L... Lung Cancer | Photodynamic Th... | 18 Years - | University College, London | |
| S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00085501 | Lung Cancer | cetuximab carboplatin paclitaxel | 18 Years - | SWOG Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
